Galaxy Balance

Galaxy Balance

By Cory SmithScienceLife Sciences
Download on the App Store

Galaxy Balance episodes

  • Intertwined Biosciences: Engineering Evolution for Human Health

    Max Rye and Evan Appleton of Intertwined Bio join Galaxy Balance to explore one of the boldest ideas in modern biology: borrowing nature’s most extreme traits and translating them into human health.

    From horses that resist liver cirrhosis to naked mole rats, bowhead whales, radiation resistant organisms, hibernating animals, and the future of humans in space, this conversation asks what becomes possible when evolution itself becomes a design library. Max and Evan explain how Intertwined Bio is using synthetic biology, gene editing, AI, virtual macrophages, and agentic systems to identify traits from extraordinary animals and test whether those adaptations can be engineered into human cells.

    We discuss liver fibrosis, DNA damage repair, innate immune engineering, longevity, space radiation, de extinction, Colossal Biosciences, the future of virtual cells, and the ethical line between therapy and enhancement.

    This is a conversation about turning science fiction into biology.

    00:00 - Introduction to Intertwined Bio and their innovative approach

    01:01 - The origins and motivations of Max and Evan in biotech

    04:56 - Scientific foundation: Borrowing traits from long-lived and resilient animals

    07:16 - Why now? Recent technological advances enabling these innovations

    10:46 - Role of AI in understanding complex biological systems and virtual cell modeling

    14:17 - Delivery strategies for genetic modifications in humans

    18:19 - Regulatory pathways and ethical boundaries in gene editing

    22:25 - The potential of junk DNA variants and regulatory engineering

    27:09 - The potential impact on sports animals and broader applications

    31:12 - Industry landscape, collaboration, and competition

    33:21 - Building a startup: team dynamics, trust, and early steps

    35:58 - Insights on other biotech ventures like AstroMech and their directions

    38:39 - Space applications: radiation resistance, hibernation, and life support systems

    43:01 - Prioritizing targets using AI and high-throughput screening

    48:31 - Broader prospects: aging, longevity, and the OZEMPIC effect

    52:44 - Focus on innate immune system engineering and virtual cell development

    57:15 - Strategies for macrophage gene editing and cell type targeting

    1:01:36 - Bottlenecks in lab throughput and cell growth limitations

    1:04:30 - The influence of science fiction on biotech innovation and ethical outlooks

    1:06:14 - Closing thoughts: science fiction as inspiration and the rapid transition of ideas into reality

    1 hr 8 min
  • Charles Fracchia: Securing the Bioeconomy

    In this episode of Galaxy Balance, I sit down with Charles Fracchia to explore the emerging infrastructure layer of synthetic biology. We discuss the future of secure and scalable bioengineering, the role of community laboratories in accelerating innovation, and how biology is evolving into a programmable technology platform. Charles shares the story behind BioBright, the creation of Bio-ISAC, and the broader challenge of building resilient systems for a world where genetic engineering becomes increasingly accessible.

    The conversation moves from cyberbiosecurity and open science to AI-driven biological design, scientific culture, and the growing overlap between software engineering and biotechnology. We also explore the long-term future of human enhancement, decentralized science, and how science fiction continues to shape the ambitions of the next generation of builders working at the frontier of biology.

    Timestamps:

    00:00 - Overcoming cynicism in AI's role in biosecurity

    00:40 - Introduction to Charles Fracchia and his pioneering work

    02:07 - Charles's background and journey into biotech innovation

    04:01 - Balancing classical education with trial-by-fire experience

    06:26 - AI as a search tool versus experimental center in biology

    08:28 - Developing AI systems for biological experiment automation

    11:35 - The founding and evolution of Black Mesa and its mission

    14:26 - The importance of digital batch records and AI-assisted QA QC

    16:06 - AI's role in drug development, safety, and traceability

    18:44 - Ensuring trust and integrity in AI models for biotech applications

    22:51 - Addressing data poisoning and ensuring model robustness

    24:45 - Strategies for verifying biological data integrity through cryptography and blockchain

    33:55 - Future threats like AI-driven bio weapons and safeguarding strategies

    42:48 - The importance of operational innovation in accelerating bioeconomy growth

    58:25 - Influence of science fiction on biosecurity and innovation

    60:11 - Advice for emerging scientists in a rapidly changing landscape

    1:02:53 - Closing remarks and future outlook from Charles Fracchia

    1 hr 3 min
  • Tyler Todt: Discipline Over Dopamine

    What if the most powerful form of human optimization has nothing to do with biotech?

    In this episode of Galaxy Balance, Cory sits down with Tyler Todt, who has built a platform around physical health, mental resilience, and intentional living. While the world races toward gene editing, AI, and synthetic biology, Tyler focuses on something more immediate: how daily habits, environment, and mindset shape the trajectory of your life.

    They explore the tension between technological enhancement and human discipline, from fertility and genetic selection to Neuralink and simulated realities. Along the way, Tyler shares how small, consistent changes transformed his health, marriage, and purpose, and why most people fail by trying to do too much at once.

    Timestamps:

    00:00 - Small diet tweaks for improved energy and health

    00:11 - The value of movement and daily habits in life optimization

    00:44 - Introducing Tyler Todt’s background and mission

    01:12 - Tyler’s journey from normal life to disciplined optimization

    02:17 - Marriage, weight gain, and mental health struggles in the journey

    03:08 - Creating intentional rules to improve life quality

    04:08 - Mindset shifts for sustainable health improvements

    04:45 - Challenges in maintaining motivation and overcoming setbacks

    05:02 - Tips for starting small and building routines

    06:01 - The neuroscience of habits and pattern creation

    07:27 - The importance of grace and balance in biohacking

    08:23 - Brain's autopilot and neural pathways in behavior change

    09:16 - Ethical debates around reproductive biotech advances

    09:43 - The use of stem cells in fertility and new treatments

    10:32 - The future of gene editing and embryo selection

    13:33 - Ethical considerations of genetic trait modification

    15:35 - The potential dangers of designer traits and societal impacts

    16:20 - Risks of focusing on narrow breeding goals

    16:49 - Natural genetic variation and evolutionary trade-offs

    17:09 - The double-edged sword of certain genetic traits like sickle cell

    18:16 - Limitations of current genetic understanding and AI's potential

    19:16 - Advances in DNA reading, writing, and CRISPR technology

    20:03 - The ethical dilemmas of germline modifications and human enhancement

    21:26 - The future of human evolution and the possibility of multiple iterations

    22:16 - Space exploration, colonization, and interstellar travel

    23:05 - The societal and ethical implications of AI-enhanced humans

    24:33 - Neural interfaces, Neuralink, and virtual reality futures

    25:35 - The allure and dangers of immersive digital worlds

    26:13 - The role of genuine human experiences versus synthetic life

    27:32 - The societal challenges of technological inequality

    28:02 - The quest for extraterrestrial life and the Fermi paradox

    39:15 - The potential for hidden advanced technologies and secret projects

    40:44 - The vastness of space and the search for alien life

    45:57 - Global cooperation and the importance of humanity's future

    46:55 - UFOs, alien encounters, and government disclosures

    49:40 - Living in a universe of uncertainties and existential risks

    50:14 - Science fiction recommendations: The Matrix and beyond

    50:53 - Advice for aspiring longevity explorers: control, curiosity, and consistency

    52:25 - Mental health, nervous system management, and daily reflection

    53:01 - Final thoughts and appreciation for innovative minds in health science

    54 min
  • TJ Cradick: Building the Future of Genome Editing

    Genome editing has moved from experimental concept to FDA approved medicine in less than a generation. Few people have been closer to that transformation than TJ Cradick.

    TJ was one of the earliest pioneers in programmable biology, helping shape the field from the era of zinc finger nucleases through the rise of CRISPR and next generation editing systems. As the second employee and Head of Genome Editing at CRISPR Therapeutics, he helped lay the scientific foundation for Casgevy, the first FDA approved CRISPR therapy. Later, at Excision BioTherapeutics, he worked on some of the first in vivo CRISPR therapies targeting latent HIV reservoirs.

    In this episode, we dive deep into the evolution of genome engineering. We explore the transition from protein engineered nucleases to scalable CRISPR guide libraries, and the growing importance of delivery technologies capable of targeting tissues beyond the liver. TJ explains how off target analysis evolved from primitive assays into massively parallel sequencing pipelines and why the future of gene editing depends just as much on delivery and manufacturing as the editing enzymes themselves.

    We also discuss the hidden challenges behind FDA approval, the realities of scaling genome editing therapies, the future of in vivo editing, and the ethical questions surrounding human germline engineering.

    This conversation is a rare look inside the engineering, regulation, and philosophy of one of the most transformative technologies humanity has ever developed.

    ·       0:00 - Science Fiction to Science Fact

    ·       0:23 - Cutting Edge of Science

    ·       0:37 - Introduction to TJ Cradick

    ·       1:06 - CRISPR Therapeutics and Beyond

    ·       1:42 - Early Interest in Science

    ·       2:12 - Academic Journey

    ·       3:08 - Transition to Biotech

    ·       4:04 - Zinc Finger Nucleases

    ·       5:28 - Evolution of Screening Technologies

    ·       6:48 - CRISPR Libraries and High Throughput Screens

    ·       8:07 - New Technologies in Gene Editing

    ·       9:15 - Off-Target Effects and Assays

    ·       11:23 - Future Opportunities in Gene Editing

    ·       13:18 - Regulatory Challenges

    ·       16:24 - Cost Challenges in Genome Editing

    ·       18:22 - Manufacturing and Delivery Innovations

    ·       20:14 - Delivery Challenges and Innovations

    ·       22:30 - Capsid Design and Blood-Brain Barrier

    ·       24:01 - Viral vs. Non-Viral Delivery Systems

    ·       27:19 - IP Limitations and CRISPR Variants

    ·       30:31 - Target Selection for Therapeutics

    ·       34:03 - Precise Repair Technologies

    ·       37:03 - Off-Target Effects in Gene Editing

    ·       42:31 - Genetic Instability in Edited Cells

    ·       46:20 - Human Germline Engineering

    ·       49:19 - CRISPR for Viral Cure

    ·       51:27 - Regulatory Path Improvements

    ·       54:20 - Balancing Speed and Safety

    ·       57:03 - Advice for Future Scientists

    1 hr
  • Nabiha Saklayen: From Physics to Scalable Cell Therapies

    What does it actually take to manufacture biology at scale?

    In this episode of Galaxy Balance, Cory Smith sits down with Nabiha Saklayen, CEO and co-founder of Cellino, to explore the future of cell therapy manufacturing. Trained in physics and biophotonics, Nabiha is applying principles from semiconductor fabrication to one of the hardest problems in medicine: turning powerful cell therapies into scalable, reliable products.

    The conversation dives into the core challenges of iPSC variability, autologous versus allogeneic strategies, and why manufacturing remains the primary bottleneck preventing these therapies from reaching patients. Nabiha explains Cellino’s approach, combining AI, imaging, and laser-based systems to create a closed, automated platform for cell production.

    They also explore how AI is reshaping biology, how scientists are evolving into computational operators, and what the future lab looks like as automation and intelligence converge. From Artemis missions to the arrow of time in reprogramming, this episode connects physics, biology, and the long-term future of engineered life.

    This is a deep look at the infrastructure layer of biofuturism and what must be true for living medicines to reach the world at scale.

    00:00 - The importance of curiosity and bold thinking in science and technology

    00:11 - Nabiha Saklayen’s background and childhood fascination with space

    02:01 - Her journey through physics, biophysics, and motivations behind her work

    03:24 - Early influences from diverse cultures and educational choices

    06:17 - How personal loss shaped her scientific focus on biomedicine

    08:40 - Insights on Artemis moon mission and space biology innovations

    12:27 - Inspiring the next generation: fostering curiosity in children

    14:20 - AI as a tool for biology and the significance of large language models

    17:03 - The origins of Cellino: applying light-based manufacturing methods

    20:22 - Cellino’s optical bioprocess and steps toward clinical-scale production

    22:23 - Addressing variability in iPSC reprogramming and quality control

    26:32 - Regulatory milestones and FDA collaborations in advanced therapies

    30:27 - The role of automation and dashboards in scalable cell manufacturing

    36:52 - Visualizing the process from donor cell to differentiated therapy

    40:35 - Maintaining sterility and process control in cell banking

    45:40 - How AI interfaces with robotics and the role of scientists in automated development

    46:04 - The physics of cell removal using bubbles and laser technology

    49:20 - How AI and machine learning optimize manufacturing processes and data management

    54:54 - Advice for students passionate about science and innovation

    57:19 - Future of human creativity and AI partnership in work and art

    59:05 - Speculating on the creation or existence of AGI and its first questions

    1:00:03 - The influence of science fiction on Nabiha’s worldview and recommended books

    1 hr 2 min
  • Noah Davidsohn: Engineering Longevity at the Genetic Level

    What if aging is not a collection of diseases, but a system-level failure we can intervene in?

    In this episode of Galaxy Balance, Cory Smith sits down with Noah Davidsohn, co-founder and CSO of Rejuvenate Bio, to explore a new approach to longevity rooted in gene therapy and systems biology.

    Noah’s work focuses on treating aging at its source by rebalancing key biological pathways across the body. Instead of targeting one disease at a time, his team is developing combination gene therapies designed to improve function across multiple organs simultaneously.

    Rejuvenate Bio is currently raising on Wefunder. This is a rare opportunity to invest in a scaling biotech on the same terms as their VC partners. If our conversation resonated with you, this is your chance to join what Dr. Noah Davidsohn is building. Learn more and invest at wefunder.com/rejuvenatebio

    00:00 - Replacing organs to reverse aging: science fiction or imminent reality

    00:34 - Welcome to Galaxy Balance: exploring biology and AI frontiers

    01:01 - Noah Davidson’s background and mission at Rejuvenate Bio

    01:57 - Reprogramming biological systems for systemic healthspan extension

    02:41 - The influence of sci-fi on Noah’s interest in space and longevity

    03:38 - Space exploration's crossover with biological resilience

    05:25 - The societal impact of science fiction on technological progress

    07:55 - Addressing dystopian themes in modern sci-fi and their societal reflection

    08:16 - The absence of longevity-focused sci-fi and Noah’s motivation

    09:12 - Personal story: pet dog inspired Noah’s longevity work

    10:33 - Origin of Rejuvenate Bio and its mission to treat aging

    11:57 - Combining gene therapies targeting multiple age-related diseases

    13:44 - The potential and limitations of epigenetic partial reprogramming

    14:14 - Upcoming clinical trials and safety considerations for gene therapy

    16:01 - Cyclic gene therapy and risks of permanent expression

    17:43 - Inducible gene expression systems: safety and practical considerations

    21:19 - Systemic, liver-targeted gene therapies: permanent vs. transient

    22:33 - Strategies for pet therapies and expanding to human applications

    25:47 - Manufacturing innovations reducing costs for wide-scale treatment

    27:12 - Prophylactic use of gene therapies in pets and humans

    29:08 - Targeting multiple diseases with a single systemic therapy

    30:40 - Breeds at risk for mitral valve disease and targeted therapy efforts

    33:42 - Disease-modifying treatments for fibrosis and heart failure

    36:48 - How AAV vector delivery works and safety measures in tissue targeting

    42:47 - Regulatory pathways for animal therapies and translational relevance

    44:22 - Challenges in funding and VC environment for longevity startups

    45:45 - The strategy of using animal models as a bridge to human therapies

    50:05 - Future scientific directions: partial reprogramming and cell replacement tech

    52:37 - The concept of longevity escape velocity and current progress

    53:44 - Personal longevity practices: exercise, diet, sleep, stress management

    55:27 - The role of biometric feedback devices in health monitoring

    56:54 - Emerging modalities and innovative approaches in anti-aging research

    58:24 - The ship of Theseus analogy for cell and tissue replacement

    59:37 - Philosophical questions about consciousness and identity in aging

    1:00:43 - Recommended sci-fi books for longevity and biotech enthusiasts

    1:01:39 - Career advice for aspiring scientists and interdisciplinary innovation

    1:02:45 - Wrap-up and best wishes for ongoing longevity breakthroughs

    1 hr 4 min
  • Tae Seok Moon: Engineering Biology at Planetary Scale

    Synthetic biology is entering a new phase where biology can be treated as an engineering discipline. In this episode of Galaxy Balance, Cory Smith speaks with Dr. Tae Seok Moon, professor at the J. Craig Venter Institute and a leader in synthetic biology, about the long arc from reading DNA to eventually designing biological systems from first principles.

    Tae shares his unconventional path into science. As a student in Korea he originally wanted to be a poet before choosing chemistry and engineering. that early philosophical curiosity about existence ultimately drew him toward biology and the story of life emerging from molecules after the Big Bang.

    The conversation explores the evolution of synthetic biology through a literary metaphor. DNA sequencing allowed scientists to read the letters of life. Genome synthesis made it possible to write those letters. Gene editing introduced a way to revise existing text. Moon argues that most of modern biotechnology still resembles editing or copying nature rather than true creative writing in biology. Only recently have tools such as AI-guided protein design begun to generate entirely new biological "words."

    Moon also discusses the legacy of Craig Venter and the creation of the first cell controlled by a synthetic genome. That milestone demonstrated that digital DNA stored in a computer can be turned back into a functioning biological system, a reversal of sequencing that points toward a future where genomes become programmable substrates.

    The episode then moves into Moon's work at the intersection of space exploration and biotechnology. His team demonstrated that bacteria can produce the antioxidant lycopene in simulated microgravity using resources that would be available on the Moon or Mars. The system converts plastic waste into a carbon source and processes nutrients derived from human waste to fuel microbial production, a concept aimed at enabling sustainable life support systems during long-duration space missions.

    Beyond space exploration, Moon leads global collaborations focused on transforming waste streams into useful chemicals and materials. He argues that the constraints of space missions mirror the resource challenges facing Earth today, from plastic pollution to carbon emissions. Technologies developed for closed-loop life support in space may also help build circular bioeconomies of Earth.

    The conversation also tackles the rapid rise of artificial intelligence in biology, the future of scientific publishing, and the challenge of maintaining human creativity in an era of AI-generated research and communication. Moon reflects on what may remain uniquely human: genuine motivation, emotion, and the drive that comes from purpose and connection.

    The episode closes with a story about one of Moon's former students who overcame severe adversity and later helped lead the development of a COVID vaccine. For Moon, that journey captures the deeper motivation behind science. The next generation of researchers will face immense challenges, but their work will shape the technologies that improve life across the planet.

    This episode explores the frontier where biology becomes designable, where microbes may help sustain human life beyond Earth, and where the language of DNA may one day evolve from editing nature to composing entirely new forms of life.

    0:00 - Introduction
    1:01 - Tae Seok Moon Background
    2:34 - From Poet to Scientist
    8:26 - DNA as Language & Creation
    12:37 - Synthetic Cells & Venter
    18:31 - Microbes in Space
    25:47 - ISS & Space Experiments
    29:22 - Closed Ecosystems Challenge
    32:25 - Solving Global Problems
    37:44 - Science Fiction Influence
    40:36 - AI in Synthetic Biology
    50:38 - Future of Scientific Publishing
    1:01:10 - Advice for Young Scientists

    1 hr 9 min
  • Pranam Chatterjee: Programming Life with AI

    What if biology could be engineered the way we engineer software?

    In this episode of Galaxy Balance, I'm joined by Pranam Chatterjee, Assistant Professor at the University of Pennsylvania and leader of the Programmable Biology Group, working at the intersection of AI, synthetic biology, and next-generation therapeutics.

    Pranam's work is shaping a future where generative models can design peptides and biologics from sequence data alone, enabling a new era of programmable medicine.

    We explore how Pranam went from studying religion and philosophy to transferring into MIT and building cutting-edge computational tools for biology. We dive into his time in George Church's lab, where early computational strategies helped spark the origins of Gameto, and how that work evolved into today's iPSC-derived ovarian support cell technologies now entering clinical trials.

    From there, we go deep into the frontier of AI-driven molecular design:

    • Do we actually need protein structure to design effective therapeutics?

    • How do we optimize binding, toxicity, permeability, and immunogenicity simultaneously?

    • What does "virtual cell" really mean, and why does mapping cell states matter?

    • How close are we to "vibe coding biology," where natural language becomes the interface to biological engineering?

    We also discuss the future of automation, robotics, and agentic AI in biology, as well as the ethical risks of democratized generative models in biotech.

    This conversation is a window into the net phase of human capability: not just ready biology, but designing it.

    00:00 - Introduction to AI-driven therapeutic peptide design
    01:05 - Background of Pranam Chatterjee's journey from religion to science
    02:50 - The evolution of AI models in synthetic biology
    05:17 - Key milestones: from modeling to clinical applications like Gameto
    08:19 - The founding story of Gameto and major breakthroughs
    12:20 - Expanding into disease targeting and regenerative medicine
    17:50 - The shift to virtual cell and organism design
    22:16 - Tools for peptide design: Peptune and PEPMLM
    25:04 - Generative modeling with language models and functional constraints
    28:32 - Imagining programmable organisms and mythical creatures
    29:41 - Hardware importance and future of vibe-coded biology
    31:54 - The role of automation and robotics in biotech labs
    33:47 - Mentoring students for the AI-biotech revolution
    36:50 - Targeting rare diseases and regulatory considerations
    40:34 - Global competition, safety, and ethics in biotech innovation
    44:44 - Designing molecules with AI: from complexity to deliverability
    45:09 - Data needs: where to find diverse biological datasets
    47:49 - The rise of AI agents in scientific research
    50:12 - Ethical responsibilities in AI bioengineering
    52:38 - Safeguards against harmful biotech applications
    55:22 - Thoughts on artificial general intelligence and human purpose
    58:40 - How science fiction inspires biotech innovation
    1:00:13 - Book recommendations and closing thoughts

    1 hr 1 min
  • Jonathan Scheiman: Microbes of Elite Performance

    In this episode of Galaxy Balance, Cory Smith speaks with Dr. Jonathan Scheiman, co-founder and CEO of FitBiomics, about the science of elite performance, microbiome discovery, and the future of metabolic health.

    Jonathan shares his journey from Division I basketball player to biomedicine PhD and postdoctoral researcher in the Church Lab, where unconventional ideas are encouraged and ambitious biology is the norm

    His central question was simple but radical: instead of studying disease, what if we studied peak human performance?

    That question led to a longitudinal study of Boston Marathon runners, where his team collected microbiome samples before and after intense endurance events. The data revealed a striking pattern. One microorganism, Veillonella, spiked in abundance immediately after the marathon

    Further analysis showed that this microbe uniquely metabolizes lactate and converts it into short-chain fatty acids such as propionate

    Lactate is often misunderstood as a fatigue molecule. In reality, it is a normal metabolic fuel. When produced in excess during intense exercise, it accumulates in the bloodstream. Scheiman’s work suggests that a portion of circulating lactate is shuttled to the gut, where Veillonella uses it as a carbon source, producing metabolites that may support mitochondrial function, muscle recovery, glucose utilization, and anti-inflammatory pathways

    The episode explores:

    • How elite athletes may represent a rare biological phenotype comparable in rarity to centenarians
    • Why the microbiome can shift rapidly in response to exercise intensity
    • The challenges of culturing and scaling strict anaerobic microbes for commercialization
    • The regulatory pathway differences between therapeutic microbiome interventions and consumer health products
    • How AI and machine learning enabled the discovery of novel microbial signals in complex datasets

    The conversation expands into longevity, mitochondrial efficiency, digital health integration, and the idea of FitBiomics as a biological data company rather than simply a probiotic brand

    Scheiman also reflects on science fiction, pop culture, and storytelling as forces that shape technological ambition, drawing connections between Marvel, AI, and biotechnology innovation

    This episode sits at the intersection of microbiome science, metabolic optimization, artificial intelligence, and the long-term future of human performance.

    If the biology of elite athletes can be decoded and translated, the implications extend far beyond sport.

     

    00:00 - Introduction to microbiome insights for human performance
    02:20 - Personal journey from sports to biotech innovation
    05:28 - How elite athletes inspired microbiome research
    09:04 - Approaching human performance limits and societal health impacts
    13:48 - Early discoveries: microbiome sampling from Boston Marathon runners
    27:19 - The breakthrough finding: Vianella's role in fatigue and endurance
    30:19 - Scientific steps to isolate and validate Vianella
    33:29 - Regulatory considerations for microbiome supplements versus therapeutics
    36:04 - Prevalence of Vianella across different athletes and individuals
    40:51 - Microbiome as a dynamic, modifiable biomarker for health and sport
    45:37 - Metabolism, mitochondria, and longevity interconnected through microbiome dynamics
    49:16 - Influences of science fiction on biotech imagination and vision
    57:39 - Future applications: wearables, continuous monitoring, and AI in microbiome health
    1:00:46 - Vision for FitBiomics’ role in health innovation and societal impact

    1 hr 2 min
  • Yuanhao Qu: Programming Biology with AI

    Biology is becoming programmable.

    In this episode of Galaxy Balance, Cory Smith speaks with Yuanhao Qu, President and Co-Founder of PhyloBio, about the emergence of AI driven biological discovery. Yuanhao represents a new generation of scientists who combine genome engineering with large language models to build systems that can reason about DNA and accelerate research across the life sciences.

    The conversation explores Yuanhao’s journey from early cancer research to developing CRISPR-GPT and Biomni, tools designed to help scientists design experiments, analyze data, and navigate the growing complexity of biological research. The discussion then moves to the founding of PhyloBio and the idea of an integrated biology environment where AI agents collaborate with human researchers.

    We examine the future of genome engineering, the challenges of delivering gene therapies, and how AI agents may soon assist in designing experiments, generating hypotheses, and exploring massive biological datasets. They also discuss the possibility of automated laboratories, the evolving role of scientists in an AI-augmented research ecosystem, and the ethical boundaries that must guide advances in synthetic biology.

    The episode closes with a discussion of science fiction, biosecurity, and the long term vision of AI systems that help humanity understand life at every scale.

    If biology becomes a language, the next frontier will belong to those who learn how to speak it.

    Phylo is a research lab developing cutting-edge agentic intelligence to accelerate discovery for biomedical scientists. They are building Biomni Lab, an integrated biology environment that leverages the latest AI to transform how biologists work. Explore it at biomni.phylo.bio

    Phylo is also actively hiring. Learn more at phylo.bio/careers

    Timestamps:

    00:00 - Embracing rapid change and AI tools in biology
    02:24 - Yuanhao’s background and motivation to cure cancer
    04:11 - Analyzing complex diseases with genomics and AI
    07:25 - Switching focus to AI-guided discovery and CRISPR engineering
    12:13 - Building and deploying CRISPR-GPT to democratize gene editing design
    16:23 - How AI enhances the role of scientists rather than replacing them
    20:52 - The story behind PhiloBio and its vision to accelerate biotech innovation
    24:01 - Developing BioOmni: an AI environment for biological research
    28:21 - The future of AI in autonomous labs and the challenge of human-in-the-loop systems
    36:33 - Ensuring safety and predicting oncogenic risk in genome engineering
    42:49 - Advances needed in delivery mechanisms for gene therapies
    45:02 - Insights into human intelligence evolution and AI’s role in discovery
    51:04 - The significance of memory, personalization, and continuous learning in AI agents
    55:06 - Ethical dilemmas in human germline modification and societal impacts
    58:30 - Speculations on life’s prevalence in the universe and the Dark Forest hypothesis
    59:46 - Advice for aspiring scientists eager to innovate with AI

    1 hr 2 min

About Galaxy Balance

From the publisher's feed

Galaxy Balance explores the frontier where biology, technology and consciousness meet. Each episode brings together pioneers shaping our collective future, from genome engineers and AI builders to…